Scholarlink

<p>The regulatory approval of implantable medical devices (IMDs) remains a complex and evolving challenge, particularly across Medical Device Single Audit Program (MDSAP) regions. This review critically analyzes regulatory frameworks in the USA, Canada, Brazil, Japan, and Australia, focusing on disparities in approval processes, risk classification, and post-market surveillance obligations. Emphasis is placed on the integration of international standards specifically ISO 13485 for quality management and ISO 14971 for risk management as foundational tools in compliance strategies. The study also explores the financial and procedural implications of MDSAP audits, the current progress toward regulatory harmonization, and the emerging role of artificial intelligence in real-time device monitoring. By highlighting systemic barriers and proposing adaptive pathways, this work underscores the need for global alignment to enhance patient safety and accelerate market access for the next-generation IMDs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Regulatory Complexities in MDSAP: Challenges and Pathways for Implantable Medical Device Approval

  • 期刊论文

  • 发表日期：

    2025年5月21日

查看全文
  • Smita Kumbhar,
  • Shreya Khadtare,
  • Snehal Zoman,
  • Deepakshi Rane,
  • Vipul Patel,
  • Somnath Bhinge

摘要

The regulatory approval of implantable medical devices (IMDs) remains a complex and evolving challenge, particularly across Medical Device Single Audit Program (MDSAP) regions. This review critically analyzes regulatory frameworks in the USA, Canada, Brazil, Japan, and Australia, focusing on disparities in approval processes, risk classification, and post-market surveillance obligations. Emphasis is placed on the integration of international standards specifically ISO 13485 for quality management and ISO 14971 for risk management as foundational tools in compliance strategies. The study also explores the financial and procedural implications of MDSAP audits, the current progress toward regulatory harmonization, and the emerging role of artificial intelligence in real-time device monitoring. By highlighting systemic barriers and proposing adaptive pathways, this work underscores the need for global alignment to enhance patient safety and accelerate market access for the next-generation IMDs.